Press release
The growing technological advancements coupled with the rapidly rising consumer awareness are anticipated to create momentum in the market and drive the growth of pharmacogenomics tests, says a report by RationalStat
The "Global Pharmacogenomics Market Analysis and Forecast, 2019-2028" report by RationalStat assesses the regional market based on technology, application, end user, and region. A detailed market analysis report provides an overall historical and future market size in terms of market value (US$ Million) and with a comprehensive market trend analysis (year-on-year growth). The market share analysis, growth of the insurance industry, an overview of the competition, strategic imperatives, plans and strategies, key application, potential growth driver, recent R&D of pharmacogenomics across the globe, and competition analysis for the target players evaluated in the global pharmacogenomics market study.Market Overview and Dynamics
The global pharmacogenomics market was valued at US$ 6.4 billion in 2022 and is expected to grow at a robust growth rate of around 8.4% during the forecast period 2022-2028. The global pharmacogenomics market is primarily driven by technological advancements coupled with growing government initiatives globally.
In addition, the customer and patients are becoming aware of the use cases of pharmacogenomics. Therefore, the health-focused and fitness freak population are expected to create demand for pharmacogenomics as they are specific about the ingredient of the medication.
Explore more about this report - Request for Sample and Scope of the Study
https://store.rationalstat.com/store/global-pharmacogenomics-market/#tab-ux_global_tab
Market Drivers and Trends of the Global Pharmacogenomics Market
The rapidly growing government initiatives are expected to fuel the adoption of pharmacogenomics through funding research, providing reimbursement for pharmacogenomics-based tests, and promoting the use of pharmacogenomics in clinical practice.
Governments across the globe are focusing on the use of pharmacogenomics as it is backed by extensive research and supported by multiple clinical studies published in peer-reviewed journals, which helps doctors and healthcare professionals to make informed decisions about medication selection.
All these factors are anticipated to drive the demand for pharmacogenomics and bring revenue from the healthcare industry as well as healthcare professionals. Moreover, new drugs are being developed that are specifically designed to be used in conjunction with pharmacogenomics. These drugs are designed to target specific genetic variants that are associated with drug response. This will further fuel the sales revenue for the global pharmacogenomics market in the upcoming years.
Segmental Analysis: Global Pharmacogenomics Market
• On the basis of technology, DNA sequencing dominates the global pharmacogenomics market, as DNA sequencing is gaining traction and demand from hospitals, clinics, and healthcare professionals due to the growing awareness about the benefits of pharmacogenomics.
• Based on end users, Hospitals and Clinics hold the majority share of the global pharmacogenomics market, owing to the growing awareness among healthcare professionals, and other end users like Research Institutions & Academic Institutes are expected to grow at a significant rate in the forthcoming years.
Competition Analysis and Market Structure
The global pharmacogenomics market is fragmented in nature with the presence of various players operating in the region. Leading companies operating in the pharmacogenomics market are focusing on providing coverage for all kinds of liabilities that hamper the process of pharmacogenomics.
Moreover, these players adopt various strategies to increase their market share and gain a competitive edge over other competitors in the global pharmacogenomics market. Mergers and acquisitions, partnerships, and collaborations are some of the strategies followed by industry players. Some of the key developments in the global pharmacogenomics market include,
• In February 2023, GeneDx announced that it has acquired SureGenomics, a leading provider of pharmacogenomics testing services.
• In January 2023, DNA Genotek announced the launch of its new pharmacogenomics test, the
• In December 2022, Novartis announced a partnership with Verily to develop and commercialize pharmacogenomics-based medicines.
• In November 2022, Pfizer announced the launch of its new pharmacogenomics test, the Indivior PrecisionRx.
• In January 2023, Guardant Health announced that it had acquired Genome Medical, a personalized medicine company that offers pharmacogenomics testing and consulting services.
• In February 2023, Illumina announced that it had entered into a collaboration with WuXi NextCODE to develop and commercialize pharmacogenomics-based products and services.
• In March 2023, Astellas Pharma announced that it had entered into a partnership with Verily to develop and commercialize pharmacogenomics-based medicines for cancer.
Some of the key players operating in the global pharmacogenomics market include Dynamic DNA Laboratories, Illumina Inc, OneOme LLC, Myriad Genetics Inc, Thermo Fisher Scientific Inc., AltheaDX, PacBio, Qiagen NV, Abbott Laboratories, Agilent Technologies, Novartis AG, Empire Genomics, among others.
RationalStat has segmented the global pharmacogenomics market on the basis of technology, application, end user, and region.
• Global Pharmacogenomics Market Value (US$ Million), and Market Share (2019-2028) Analysis by Technology
o DNA Sequencing
o Microarray
o Polymerase Chain Reaction
o Electrophoresis
o Mass Spectrometry
o Other Technologies
• Global Pharmacogenomics Market Value (US$ Million), and Market Share (2019-2028) Analysis by Application
o Cardiovascular Diseases
o Infectious Diseases
o Oncology
o Neurological Diseases
o Psychiatry
o Pain Management
• Global Pharmacogenomics Market Value (US$ Million), and Market Share (2019-2028) Analysis by End User
o Hospitals & Clinics
o Research Institution & Academic Institutes
o Others
• Global Pharmacogenomics Market Value (US$ Million), and Market Share (2019-2028) Analysis by Region
o North America Pharmacogenomics Market
US
Canada
o Latin America Pharmacogenomics Market
Brazil
Mexico
Rest of Latin America
o Western Europe Pharmacogenomics Market
Germany
UK
France
Spain
Italy
Benelux
Nordic
Rest of Western Europe
o Eastern Europe Pharmacogenomics Market
Russia
Poland
Rest of Eastern Europe
o Asia Pacific Pharmacogenomics Market
China
Japan
India
South Korea
Australia
ASEAN (Indonesia, Vietnam, Malaysia, etc.)
Rest of Asia Pacific
o Middle East & Africa Pharmacogenomics Market
GCC
South Africa
Turkey
Rest of the Middle East & Africa
For more information about this report
https://store.rationalstat.com/store/global-pharmacogenomics-market/
Some related reports:
https://store.rationalstat.com/store/global-rapid-medical-diagnostics-market/
https://store.rationalstat.com/store/global-ivermectin-market/
RationalStat LLC
Kimberly Shaw,
Content and Press Manager
sales@rationalstat.com
Phone: +1 302 803 5429
RationalStat is an end-to-end global market intelligence and consulting company that provides comprehensive market research reports along with customized strategy and consulting studies. The company has sales offices in India, Mexico, and the US to support global and diversified businesses. The company has over 80 consultants and industry experts, developing more than 850 market research and industry reports for its report store annually.
RationalStat has strategic partnerships with leading data analytics and consumer research companies to cater to the client's needs. Additional services offered by the company include consumer research, country reports, risk reports, valuations and advisory, financial research, due diligence, procurement and supply chain research, data analytics, and analytical dashboards.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The growing technological advancements coupled with the rapidly rising consumer awareness are anticipated to create momentum in the market and drive the growth of pharmacogenomics tests, says a report by RationalStat here
News-ID: 3100924 • Views: …
More Releases from RationalStat LLC

Latest Market Study | Global Lipstick Filling Machine Market Size, Share, & Fore …
The global lipstick filling machine market is expected to reach US$ 88.2 million by 2030, with an annual growth rate of more than 4.5%.
According to RationalStat's recent industry analysis, the Global Lipstick Filling Machine Market value is estimated at US$ 64.8 million in 2023 and is expected to rise at a strong CAGR of over 4.5% over the forecast period of 2023-2030.
Market Definition, Market Scope, and Report Overview
A lipstick…

Published Market Report | Global Railway Systems Market Size, Share, & Forecast …
The global railway systems market is expected to reach US$ 29.2 billion by 2030, with an annual growth rate of more than 3.6%.
According to RationalStat's recent industry analysis, the Global Railway Systems Market value is estimated at US$ 22.8 billion in 2023 and is expected to rise at a strong CAGR of over 3.6% over the forecast period of 2023-2030.
Market Definition, Market Scope, and Report Overview
Railway systems, also known…

Published Market Report | Global Window Blinds Market Size, Share, & Forecast 20 …
The global window blinds market is expected to reach US$ 3.7 billion by 2030, with an annual growth rate of more than 3.8%.
According to RationalStat's most recent industry analysis, the Global Window Blinds Market value is estimated at US$ 2.9 billion in 2023 and is expected to rise at a strong CAGR of over 3.8% over the forecast period of 2023-2030.
Market Definition, Market Scope, and Report Overview
Window blinds are…

Ointment and Cream Manufacturing Plant Market Report 2023 | Ointment and Cream M …
The global ointment and cream manufacturing plant market is expected to approach US$ 388.7 million by 2030, with an annual growth rate of more than 5.9%
Global Ointment and Cream Manufacturing Plant Market is valued at US$ 260.9 million in 2023 and is expected to grow at a significant CAGR of over 5.9% over the forecast period of 2023-2030, according to the published market report by RationalStat
Market Definition, Market…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…